123 related articles for article (PubMed ID: 28462836)
21. Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities.
Abouzid KAM; Al-Ansary GH; El-Naggar AM
Eur J Med Chem; 2017 Jul; 134():357-365. PubMed ID: 28431341
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors.
Fan YH; Li W; Liu DD; Bai MX; Song HR; Xu YN; Lee S; Zhou ZP; Wang J; Ding HW
Eur J Med Chem; 2017 Oct; 139():95-106. PubMed ID: 28800461
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of β-Enaminonitrile-Linked 8-Methoxy-1
Elgaafary M; Fouda AM; Mohamed HM; Hamed A; El-Mawgoud HKA; Jin L; Ulrich J; Simmet T; Syrovets T; El-Agrody AM
Front Chem; 2021; 9():759148. PubMed ID: 34881224
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of Tolmetin Hydrazide-Hydrazones and Discovery of a Potent Apoptosis Inducer in Colon Cancer Cells.
Küçükgüzel ŞG; Koç D; Çıkla-Süzgün P; Özsavcı D; Bingöl-Özakpınar Ö; Mega-Tiber P; Orun O; Erzincan P; Sağ-Erdem S; Şahin F
Arch Pharm (Weinheim); 2015 Oct; 348(10):730-42. PubMed ID: 26287512
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and antibreast cancer MCF-7 cells biological evaluation of heterocyclic analogs of resveratrol.
Du C; Dong MH; Ren YJ; Jin L; Xu C
J Asian Nat Prod Res; 2017 Sep; 19(9):890-902. PubMed ID: 27809606
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and evaluation of some 1,6-disubstituted-1H-benzo[d]imidazoles derivatives targeted PI3K as anticancer agents.
Ding HW; Yu L; Bai MX; Qin XC; Song MT; Zhao QC
Bioorg Chem; 2019 Dec; 93():103283. PubMed ID: 31585260
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antitumor activity evaluation of PI3K inhibitors containing 3-substituted quinazolin-4(3H)-one moiety.
Zhang H; Xin MH; Xie XX; Mao S; Zuo SJ; Lu SM; Zhang SQ
Bioorg Med Chem; 2015 Dec; 23(24):7765-76. PubMed ID: 26652969
[TBL] [Abstract][Full Text] [Related]
28. Novel thiosemicarbazides induced apoptosis in human MCF-7 breast cancer cells via JNK signaling.
Malki A; Elbayaa RY; Ashour HM; Loffredo CA; Youssef AM
J Enzyme Inhib Med Chem; 2015; 30(5):786-95. PubMed ID: 25363687
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and cytotoxic activities of novel hybrid 2-phenyl-3-alkylbenzofuran and imidazole/triazole compounds.
Chen W; Deng XY; Li Y; Yang LJ; Wan WC; Wang XQ; Zhang HB; Yang XD
Bioorg Med Chem Lett; 2013 Aug; 23(15):4297-302. PubMed ID: 23800685
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells.
Shaik AB; Rao GK; Kumar GB; Patel N; Reddy VS; Khan I; Routhu SR; Kumar CG; Veena I; Chandra Shekar K; Barkume M; Jadhav S; Juvekar A; Kode J; Pal-Bhadra M; Kamal A
Eur J Med Chem; 2017 Oct; 139():305-324. PubMed ID: 28803046
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and anticancer activity evaluation of some novel pyrrolo[1,2-a]azepine derivatives.
Belal A
Arch Pharm (Weinheim); 2014 Jul; 347(7):515-22. PubMed ID: 24729464
[TBL] [Abstract][Full Text] [Related]
32. Structure-based design, SAR analysis and antitumor activity of PI3K/mTOR dual inhibitors from 4-methylpyridopyrimidinone series.
Cheng H; Hoffman JE; Le PT; Pairish M; Kania R; Farrell W; Bagrodia S; Yuan J; Sun S; Zhang E; Xiang C; Dalvie D; Rahavendran SV
Bioorg Med Chem Lett; 2013 May; 23(9):2787-92. PubMed ID: 23506825
[TBL] [Abstract][Full Text] [Related]
33. Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents.
Peng W; Tu ZC; Long ZJ; Liu Q; Lu G
Eur J Med Chem; 2016 Jan; 108():644-654. PubMed ID: 26731167
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and anticancer activity of 1-acyl-3-amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives.
Bai XG; Yu DK; Wang JX; Zhang H; He HW; Shao RG; Li XM; Wang YC
Bioorg Med Chem Lett; 2012 Nov; 22(22):6947-51. PubMed ID: 23036956
[TBL] [Abstract][Full Text] [Related]
35. Structure and ligand-based design of mTOR and PI3-kinase inhibitors leading to the clinical candidates VS-5584 (SB2343) and SB2602.
Poulsen A; Nagaraj H; Lee A; Blanchard S; Soh CK; Chen D; Wang H; Hart S; Goh KC; Dymock B; Williams M
J Chem Inf Model; 2014 Nov; 54(11):3238-50. PubMed ID: 25317974
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of 2-substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl)phenyl]acetamide derivatives and evaluation of their anticancer activity.
Ozkay Y; Işikdağ I; Incesu Z; Akalin G
Eur J Med Chem; 2010 Aug; 45(8):3320-8. PubMed ID: 20451307
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and biological activity of pyridopyrimidine scaffolds as novel PI3K/mTOR dual inhibitors.
Saurat T; Buron F; Rodrigues N; de Tauzia ML; Colliandre L; Bourg S; Bonnet P; Guillaumet G; Akssira M; Corlu A; Guillouzo C; Berthier P; Rio P; Jourdan ML; Bénédetti H; Routier S
J Med Chem; 2014 Feb; 57(3):613-31. PubMed ID: 24345273
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, Biological Evaluation and Docking Studies of Sorafenib Derivatives N-(3-fluoro-4-(pyridin-4-yloxy)phenyl)-4(5)-phenylpicolinamides.
Wang M; Wu C; Xu S; Zhu Y; Li W; Zheng P; Zhu W
Med Chem; 2017; 13(2):176-185. PubMed ID: 27855595
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity.
Li X; Liu JL; Yang XH; Lu X; Zhao TT; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Jul; 20(14):4430-6. PubMed ID: 22705022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
